In addition, accumulating data indicate that changes in methylationstatus of the promoter region of the APOE genein AD patients can have a direct influence on mitochondrial function and indeedthe development of mitochondrial pathology [67, 68]. The gene discussed is APOE; the disease is Alzheimer disease.